NCT00446979View on ClinicalTrials.gov

Safety Study of UC-781 Vaginal Microbicide

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 30, 2007

Study Completion Date

October 31, 2007

Conditions
HIV Infections
Interventions
DRUG

Placebo gel

HEC (hydroxyethyl cellulose) Control Gel applied vaginally twice daily for two weeks

DRUG

UC 781

UC 781 0.1% or UC 781 0.25%, applied vaginally twice daily for two intermenstrual weeks

Trial Locations (1)

57000

Chiang Rai Health Club, Chiang Rai

All Listed Sponsors
collaborator

Ministry of Health, Thailand

OTHER_GOV

collaborator

CONRAD

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT00446979 - Safety Study of UC-781 Vaginal Microbicide | Biotech Hunter | Biotech Hunter